Latest News
|
17 May 2013
0 Likes 
Hello and welcome to a new edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.FDA's Big Week for Device Guidance and
Read More...
Latest News
|
17 May 2013
0 Likes
Capping off a week of several long-awaited guidance documents, the US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) has released yet another guidance document,
Read More...
Latest News
|
17 May 2013
0 Likes
Massachusetts U.S. Rep. Ed Markey has announced the reintroduction of legislation that he says is intended to open up clinical trial data, introducing a measure of transparency and bringing the US
Read More...
Latest News
|
17 May 2013
0 Likes
The European Medicines Agency (EMA) has announced its adoption of the International Conference on Harmonisation's (ICH) M7 guideline on controlling carcinogenic risk in pharmaceutical products when
Read More...
Regulatory Update
|
17 May 2013
0 Likes
The European Commission’s three Scientific Committees have been requested to provide a joint scientific opinion on the relationship of Synthetic Biology (SB) to genetic modification of organisms, its
Read More...
Latest News
|
17 May 2013
0 Likes
When legislators passed a sprawling piece of legislation known as the Food and Drug Administration Safety and Innovation Act (FDASIA), they considered a huge range of problems facing both the US Food
Read More...
Latest News
|
17 May 2013
0 Likes
The medical device industry has long complained that the process of obtaining regulatory approval for its devices has become increasingly difficult over the course of the last decade. But in a
Read More...
Latest News
|
17 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Is the Hatch-Waxman Act Flawed and Should the Supreme Court Fix It? (Becker's Hospital
Read More...
Latest News
|
16 May 2013
0 Likes
The US Food and Drug Administration (FDA) has announced the approval of additional indications for Simponi (golimumab), a drug manufactured by Janssen Biotech intended to treat adults with moderate to
Read More...
Latest News
|
16 May 2013
0 Likes
The US Food and Drug Administration (FDA) may be at the forefront of trying to prevent the misuse and abuse of opioid painkillers, but as two Federal Register notices this week point out, it's not the
Read More...